Any process that activates or increases the frequency, rate or extent of type IIa hypersensitivity, a type of inflammatory response [goid 1798] [evidence IEA]; Any process that activates or increases the frequency, rate or extent of type III hypersensitivity, a type of inflammatory response [goid 1805] [evidence IEA]; Any process that activates or increases the frequency, rate or extent of type I hypersensitivity, a type of inflammatory response [goid 1812] [evidence IEA]; A series of molecular signals generated as a consequence of a the binding of the Fc portion of an immunoglobulin by an Fc receptor capable of activating or perpetuating an immune response. The Fc portion of an immunoglobulin is its C-terminal constant region [goid 2431] [evidence IEA]; The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis [goid 6911] [evidence IEA]; Any series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell [goid 7166] [evidence IEA]; An immune response mediated by immunoglobulins, whether cell-bound or in solution [goid 16064] [evidence IEA]; The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein [goid 19886] [evidence IEA]; The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding [goid 30593] [evidence IEA]; Any process that activates or increases the frequency, rate, or extent of interleukin-10 production [goid 32733] [evidence IEA]; Any process that activates or increases the frequency, rate, or extent of interleukin-6 production [goid 32755] [evidence IEA]; Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production [goid 32760] [evidence IEA]; Any process that activates or increases the frequency, rate, or extent of mast cell cytokine production [goid 32765] [evidence IEA]; Any process that stops, prevents, or reduces the frequency, rate, or extent of a mast cell apoptosis [goid 33026] [evidence IEA]; The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules [goid 42590] [evidence IEA]; Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism [goid 42742] [evidence IEA]; Any process that activates or increases the frequency, rate or extent of mast cell degranulation [goid 43306] [evidence IEA]; The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors [goid 45576] [evidence IEA]; Any process that activates or increases the frequency, rate or extent of phagocytosis [goid 50766] [evidence IEA]; Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus [goid 50778] [evidence IEA]